Genocea Biosciences Inc Aktien im Umlauf
Was ist das Aktien im Umlauf von Genocea Biosciences Inc?
Aktien im Umlauf von Genocea Biosciences Inc ist 58.784M
Was ist die Definition von Aktien im Umlauf?
Im Umlauf befindliche Aktien sind alle Aktien einer Gesellschaft oder eines finanziellen Vermögenswertes, die von Anlegern genehmigt, ausgegeben und gekauft wurden und von diesen gehalten werden.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Aktien im Umlauf von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Genocea Biosciences Inc
Was macht Genocea Biosciences Inc?
Genocea's mission is to conquer cancer by developing personalized cancer immunotherapies in multiple tumor types. Our unique ATLAS™ platform comprehensively profiles each patient's T cell responses to potential targets, or antigens, on the tumor. ATLAS enables us to optimize the neoantigens for inclusion in our immunotherapies and exclude inhibitory antigens, Inhibigens™, that can exert an immunosuppressive effect. We are advancing two ATLAS-enabled programs: GEN-009, our neoantigen vaccine and GEN-011, our neoantigen-specific cell therapy using T cells derived from peripheral blood.
Unternehmen mit aktien im umlauf ähnlich Genocea Biosciences Inc
- IOL Chemicals and Pharmaceuticals hat Aktien im Umlauf von 58.706M
- IOL Chemicals and Pharmaceuticals hat Aktien im Umlauf von 58.706M
- Invesco Asia Trust Plc hat Aktien im Umlauf von 58.707M
- Cyon Exploration hat Aktien im Umlauf von 58.725M
- Teleperformance SE hat Aktien im Umlauf von 58.733M
- Clifton Mining Co hat Aktien im Umlauf von 58.771M
- Genocea Biosciences Inc hat Aktien im Umlauf von 58.784M
- Jiulian Resources hat Aktien im Umlauf von 58.787M
- B.C. Power Controls hat Aktien im Umlauf von 58.800M
- B.C. Power Controls hat Aktien im Umlauf von 58.800M
- Iliad SA hat Aktien im Umlauf von 58.818M
- GTT Communications Inc hat Aktien im Umlauf von 58.820M
- California Water Service hat Aktien im Umlauf von 58.825M